Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly L Sullivan

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Neurology|April 19, 2014
Author responseRoongroj Bhidayasiri, Stanley Fahn, Gary S Gronseth, et al.
Neurology|January 14, 2014
Author responseRoongroj Bhidayasiri, Stanley Fahn, Gary S Gronseth, et al.
Neuropsychiatric Disease and Treatment|November 10, 2009
Sleep disorders in Parkinson's diseaseIsrat Jahan, Robert A Hauser, Kelly L Sullivan, et al.
Clinical Neuropharmacology|June 15, 2006
Topiramate-induced psychosis in patients with essential tremor: report of 2 casesTheresa A Zesiewicz, Archer Tullidge, Jonathan Tidwell, et al.
Obesity Research & Clinical Practice|September 24, 2015
The association between arthritis and depression is intensified by excessive body weight: Findings from a US national survey, 2005-2012Maria D Politis, Krystina Johnson, Andrew R Hansen, et al.
Journal of Affective Disorders|January 8, 2026
Electronic cigarette use and postpartum depression prevalence: The pregnancy risk assessment monitoring system (PRAMS)Cyrille Kouambo Beckodro, Bernice Nsitou, Queeneth Edwards, et al.
The Journal of Clinical Psychiatry|January 22, 2025
Psychological Challenges of Adults With Severe Mental Illness During the COVID-19 PandemicKadiatou Diallo-Montford, Jessica S Schwind, Stacy W Smallwood, et al.
Clinical Neuropharmacology|June 15, 2006
The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin statusTheresa A Zesiewicz, Lynn Wecker, Kelly L Sullivan, et al.
Parkinsonism & Related Disorders|July 15, 2005
Levetiracetam for the treatment of generalized dystoniaKelly L Sullivan, Robert A Hauser, Elan D Louis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2005
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's diseaseTheresa A Zesiewicz, Kelly L Sullivan, John L Maldonado, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Neurology|April 19, 2014
Author responseRoongroj Bhidayasiri, Stanley Fahn, Gary S Gronseth, et al.
Neurology|January 14, 2014
Author responseRoongroj Bhidayasiri, Stanley Fahn, Gary S Gronseth, et al.
Neuropsychiatric Disease and Treatment|November 10, 2009
Sleep disorders in Parkinson's diseaseIsrat Jahan, Robert A Hauser, Kelly L Sullivan, et al.
Clinical Neuropharmacology|June 15, 2006
Topiramate-induced psychosis in patients with essential tremor: report of 2 casesTheresa A Zesiewicz, Archer Tullidge, Jonathan Tidwell, et al.
Obesity Research & Clinical Practice|September 24, 2015
The association between arthritis and depression is intensified by excessive body weight: Findings from a US national survey, 2005-2012Maria D Politis, Krystina Johnson, Andrew R Hansen, et al.
Journal of Affective Disorders|January 8, 2026
Electronic cigarette use and postpartum depression prevalence: The pregnancy risk assessment monitoring system (PRAMS)Cyrille Kouambo Beckodro, Bernice Nsitou, Queeneth Edwards, et al.
The Journal of Clinical Psychiatry|January 22, 2025
Psychological Challenges of Adults With Severe Mental Illness During the COVID-19 PandemicKadiatou Diallo-Montford, Jessica S Schwind, Stacy W Smallwood, et al.
Clinical Neuropharmacology|June 15, 2006
The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin statusTheresa A Zesiewicz, Lynn Wecker, Kelly L Sullivan, et al.
Parkinsonism & Related Disorders|July 15, 2005
Levetiracetam for the treatment of generalized dystoniaKelly L Sullivan, Robert A Hauser, Elan D Louis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2005
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's diseaseTheresa A Zesiewicz, Kelly L Sullivan, John L Maldonado, et al.
Pageof 7